13F filing recap · Q2 2026
What did Patient Capital Management buy in Q2 2026?
Reported stock-position changes between this filing and the previous one.
Stock value
$3.01B
Positions
39
Estimated turnover
15.2%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Quarter in review
Patient Capital Management opened new positions in Global Payments and Genius Sports while exiting its iShares Bitcoin Trust ETF. The firm substantially increased its Chime Financial stake and dramatically added to its Fidelity Wise Origin Bitcoin Fund. Notable trims included Illumina, Noble Corporation, and Dave & Buster’s Entertainment, while Adobe and Sofi Technologies saw moderate additions.